NCT05887505Not yet recruiting
Effects of Vitamin D Status and Multiple Mega-dose Supplementation on Health Care Disparities in Perioperative Patients With Hepatocellular Carcinoma Receiving Hepatectomy
Source: ClinicalTrials.gov · Last updated 6 Jun 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
High concentrations of parathyroid hormone (PTH) are common in patients with hepatocellular carcinoma (HCC). This study is aimed to investigate effects of vitamin D status and its multiple mega-dosage supplementation on PTH and clinical outcomes in HCC patients before and after hepatectomy. It's a single-center, prospective, parallel, double-blind, placebo-controlled study for 120 eligible subjects. The subjects will receive consecutively 3-day intervention treatments from 7th day before surgery. 30-day postoperative mortality, postoperative complications, and laboratory data will be evaluated.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 2 May 2023
- Start date
- 9 Jun 2023
- Primary completion date
- 1 Dec 2027
- Lead sponsor
- Taoyuan General Hospital
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT05887505
What you commit to
- Study type: Interventional
- Planned participants: 120
- From 9 Jun 2023 to the primary completion date, 1 Dec 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- 4\. Pregnant women or plan to become pregnant within 3 months after surgery
Other illness
- 1\. Using estrogen drugs, bisphosphonates, or drugs for bone disease.
- 5\. Autoimmune hepatitis (AIH)
Lab values
- 2\. Consume calcium tablets within 2 weeks before operation
Other
- 3\. Sarcoidosis, multiple myeloma
- 6\. Early liver recurrence
- 7\. Used to participate in other clinical trials
Who the study is looking for
- 1\. ≥ 20-year HCC subjects receiving laparoscopic hepatectomy
- 2.Sign the informed consent
Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.